165 related articles for article (PubMed ID: 21370305)
1. Structure analysis reveals the flexibility of the ADAMTS-5 active site.
Shieh HS; Tomasselli AG; Mathis KJ; Schnute ME; Woodard SS; Caspers N; Williams JM; Kiefer JR; Munie G; Wittwer A; Malfait AM; Tortorella MD
Protein Sci; 2011 Apr; 20(4):735-44. PubMed ID: 21370305
[TBL] [Abstract][Full Text] [Related]
2. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.
Gerhardt S; Hassall G; Hawtin P; McCall E; Flavell L; Minshull C; Hargreaves D; Ting A; Pauptit RA; Parker AE; Abbott WM
J Mol Biol; 2007 Nov; 373(4):891-902. PubMed ID: 17897672
[TBL] [Abstract][Full Text] [Related]
4. High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2).
Shieh HS; Mathis KJ; Williams JM; Hills RL; Wiese JF; Benson TE; Kiefer JR; Marino MH; Carroll JN; Leone JW; Malfait AM; Arner EC; Tortorella MD; Tomasselli A
J Biol Chem; 2008 Jan; 283(3):1501-1507. PubMed ID: 17991750
[TBL] [Abstract][Full Text] [Related]
5. A Disintegrin and Metalloproteinase with Thrombospondin Motifs-5 (ADAMTS-5) Forms Catalytically Active Oligomers.
Kosasih HJ; Last K; Rogerson FM; Golub SB; Gauci SJ; Russo VC; Stanton H; Wilson R; Lamande SR; Holden P; Fosang AJ
J Biol Chem; 2016 Feb; 291(7):3197-208. PubMed ID: 26668318
[TBL] [Abstract][Full Text] [Related]
6. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
Nuti E; Santamaria S; Casalini F; Yamamoto K; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Marini AM; Salerno S; Taliani S; Da Settimo F; Nagase H; Rossello A
Eur J Med Chem; 2013 Apr; 62():379-94. PubMed ID: 23376997
[TBL] [Abstract][Full Text] [Related]
7. N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2).
Gilbert AM; Bursavich MG; Lombardi S; Georgiadis KE; Reifenberg E; Flannery CR; Morris EA
Bioorg Med Chem Lett; 2008 Dec; 18(24):6454-7. PubMed ID: 18974001
[TBL] [Abstract][Full Text] [Related]
8. Understanding the variability of the S1' pocket to improve matrix metalloproteinase inhibitor selectivity profiles.
Gimeno A; Beltrán-Debón R; Mulero M; Pujadas G; Garcia-Vallvé S
Drug Discov Today; 2020 Jan; 25(1):38-57. PubMed ID: 31513929
[TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18.
Zeng W; Corcoran C; Collins-Racie LA; Lavallie ER; Morris EA; Flannery CR
Biochim Biophys Acta; 2006 Mar; 1760(3):517-24. PubMed ID: 16507336
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.
Atobe M; Maekawara N; Kawanishi M; Suzuki H; Tanaka E; Miyoshi S
Bioorg Med Chem Lett; 2013 Apr; 23(7):2111-6. PubMed ID: 23453072
[TBL] [Abstract][Full Text] [Related]
12. Aggravation of ADAMTS and matrix metalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes -- possible pathogenic role in osteoarthritis.
Prasadam I; Crawford R; Xiao Y
J Rheumatol; 2012 Mar; 39(3):621-34. PubMed ID: 22247346
[TBL] [Abstract][Full Text] [Related]
13. Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.
Fabre B; Ramos A; de Pascual-Teresa B
J Med Chem; 2014 Dec; 57(24):10205-19. PubMed ID: 25265401
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.
Gendron C; Kashiwagi M; Lim NH; Enghild JJ; Thøgersen IB; Hughes C; Caterson B; Nagase H
J Biol Chem; 2007 Jun; 282(25):18294-18306. PubMed ID: 17430884
[TBL] [Abstract][Full Text] [Related]
15. Development of human neutralizing antibody to ADAMTS4 (aggrecanase-1) and ADAMTS5 (aggrecanase-2).
Shiraishi A; Mochizuki S; Miyakoshi A; Kojoh K; Okada Y
Biochem Biophys Res Commun; 2016 Jan; 469(1):62-69. PubMed ID: 26612259
[TBL] [Abstract][Full Text] [Related]
16. Substrate conformation modulates aggrecanase (ADAMTS-4) affinity and sequence specificity. Suggestion of a common topological specificity for functionally diverse proteases.
Lauer-Fields JL; Minond D; Sritharan T; Kashiwagi M; Nagase H; Fields GB
J Biol Chem; 2007 Jan; 282(1):142-50. PubMed ID: 17095512
[TBL] [Abstract][Full Text] [Related]
17. Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2).
Santamaria S; Yamamoto K; Botkjaer K; Tape C; Dyson MR; McCafferty J; Murphy G; Nagase H
Biochem J; 2015 Nov; 471(3):391-401. PubMed ID: 26303525
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MMPs and ADAM/ADAMTS.
Malemud CJ
Biochem Pharmacol; 2019 Jul; 165():33-40. PubMed ID: 30826330
[TBL] [Abstract][Full Text] [Related]
19. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T; Takada T; Suzuki T; Kakutani K; Maeno K; Doita M; Kurosaka M; Nishida K
Arthritis Res Ther; 2012 Mar; 14(2):R51. PubMed ID: 22394620
[TBL] [Abstract][Full Text] [Related]
20. Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors.
Tortorella MD; Tomasselli AG; Mathis KJ; Schnute ME; Woodard SS; Munie G; Williams JM; Caspers N; Wittwer AJ; Malfait AM; Shieh HS
J Biol Chem; 2009 Sep; 284(36):24185-91. PubMed ID: 19586907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
